Mexico´s government will continue promoting an effective pharmaceutical policy that contributes to improve the health of the population, ensuring access to safe, quality and low cost medicines, said Minister of Health, Doctor Mercedes Juan in the inauguration of the X International Meeting of Leaders of Sanitary Agencies.

Dr. Mercedes Juan also highlighted the strategy of regulation of the pharmaceutical sector, which has reduced up to 61 percent, the cost of medicines in this country.

As an example, she mentioned the liberation of 32 active substances, which belong to 357 generic medicines that represent about 71 percent of death causes in Mexico.

In relation to innovative medicines, Mexico´s Minister of Health, highlighted the establishment of a regulatory cooperation plan between the different health agencies, with the purpose to make more efficient the entry of medicines into this country.

She noted that as a result of the innovation policy in the last three years, have been issued 150 authorizations to market medicines in the 20 most important therapeutic classes, to attend the epidemiology of Mexico.

Dr. Mercedes Juan stressed the importance of the international cooperation to establish the best health regulations that benefit the patient in the access to medical products for quality, safety and efficacy.

The Tenth International Meeting of Leaders of Sanitary Agencies, brought together more than 50 countries of the five continents, including the United States, China, Japan, Brazil, European Union, Canada, Australia, South Korea, and for the first time were included, India, Russia, Spain and El Salvador.

The Commissioner of the Federal Commission Against Sanitary Risks, Dr. Mikel Arriola, said that Mexico broke the record of attendance at health summits which confirms Mexico´s ability of convocation, and its leadership in Latin America.

He said that Mexico obtained in China the headquarters unanimously, due to the improvements made by the health agency to its regulatory framework on medicines and vaccines, which were recognized and the Pan-American Health Organization in 2012 and certified by the WHO in 2014.

He explained that in the three days of work of the health summit, will be reviewed the challenges and opportunities of the global agenda on regulation of generic and biotechnological medicines, the good manufacturing practices for medicines, the models of pharmacovigilance and how to strengthen national health agencies.

Doctor Mikel Arriola said that this type meetings pretend to benefit patients in Mexico and the world, through the cooperation and regulatory convergence, allowing easy access to more and better therapies with lower costs.

In the welcoming the leaders of the health agencies, the undersecretary for Multilateral Affairs and Human Rights, Miguel Ruiz Cabañas, stressed that the Mexican government continues working for universal health coverage and the expansion of the access of the Mexican population to the best medical products.

Follow us on Twitter: @SSalud_mx y @_MJuan_